Product Description
Chlorzoxazone is used to relax certain muscles in your body and relieve the discomfort caused by acute (short-term), painful muscle or bone conditions. However, this medicine does not take the place of rest, exercise, physical therapy, or other treatments that your doctor may recommend for your medical condition (Sourced from: https://www.mayoclinic.org/drugs-supplements/chlorzoxazone-oral-route/side-effects/drg-20071933?p=1)
Mechanisms of Action: CFTR Activator
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Intravenous,Oral
FDA Designation: None *
Approval Status: Approved
Approved Countries: Argentina | Australia | Canada | Chile | China | Colombia | Croatia | Dominican Republic | Egypt | Hong Kong | Hungary | India | Indonesia | Jordan | Korea | Lebanon | Malaysia | Mexico | Peru | Romania | Russia | Saudi Arabia | Slovenia | Sweden | Taiwan | Turkey | United Arab Emirates | United States | Vietnam
Approved Indications: None
Known Adverse Events: None
Company: Oncotherapeutics
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: United States
Active Clinical Trial Count: 1
Highest Development Phases
Phase 2: Breast Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Sarcoma
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| STUDY00026643 | P2 |
Not yet recruiting |
Breast Cancer|Prostate Cancer|Sarcoma|Pancreatic Cancer|Ovarian Cancer |
2027-12-31 |